Form EFFECT Ovid Therapeutics Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 24, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- B.Riley on Ovid Therapeutics Inc (OVID): 'one of our top picks from last week's B. Riley MMV Summit'
- Throw Away the Urn! New Digital DNA AGI Robots Let Loved Ones Live for 500 Years (Veterans First for America)
- Sheng Qu Reconstructs the Full-Chain Basic Education Ecosystem: Five Standards, Thirteen Digital Tools, and Over Twenty Research Outputs Bridge the Implementation Loop from Classroom Innovation to Ind
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
